Benefit and risk of methotrexate treatment in rheumatoid arthritis.
نویسندگان
چکیده
This is a literature review on the efficacy and toxicity of low dose weekly methotrexate treatment in rheumatoid arthritis. Personal recommendations on dosing and monitoring (of) the drug are given.
منابع مشابه
Liver Toxicity in Rheumatoid Arthritis Patients Treated With Methotrexate
Background:Methotrexate (MTX) is one of the most commonly used disease-modifying antirheumatic drugs in the treatment of rheumatoid arthritis (RA) which can be associated with toxic effects on different organs. This study was designed to investigate the hepatotoxic effects in RA patients treated with MTX. Methods: In this cross-sectional observational study, RA patients who received standard d...
متن کاملThe effects of Cerium oxide nanoparticles on the rat model of rheumatoid arthritis
Background & aim: The previous document indicated that Cerium oxide nanoparticles (CeO2-NPs), possess an astonishing pharmacological potential due to their antioxidant and anti-inflammatory properties. This study was designed to evaluate the effects of CeO2-NPs on the rheumatoid arthritis (RA) induced by Complete Freund's adjuvant in Wistar Rats. Methods: Forty male Wistar rats were divided int...
متن کاملAssessment of hepatic fibrosis by transient elastography in rheumatoid arthritis patients receiving methotrexate
Background and Aim: Methotrexate (MTX) is commonly used in the treatment of diseases such as rheumatoid arthritis (RA) but, its hepatotoxicity potential, always has been a major concern. The aim of this study is to determine the rate of liver fibrosis by transient elastography (TE) method and its relationship with cumulative dose of MTX and duration of treatment, in rheumatoid arthritis patient...
متن کاملهپاتوتوکسیسیتی متوتروکسات؛ خطری که نباید نادیده گرفته شود: معرفی 4 بیمار و مرور مطالب کاربردی
Introduction: Methotrexate is used increasingly for treatment of some diseases such as rheumatoid arthritis, psoriasis and Crohn. Bone marrow suppression, mucocutaneous lesions, pneumonitis, and hepatotoxicity are major side effects of this drug. Since methotrexate toxicity is dose dependent and is usually administered with low dose via a weekly regimen, its side effects are not commonly seen. ...
متن کاملA Case of Acute Myeloid Leukemia Caused by Low Dose Methotrexate Used to Treat a Rheumatoid Arthritis Patient
Methotrexate is an anti-rheumatic agent used as a first-line tretment for rheumatoid arthritis. Hematological malignancies like lymphoma or acute myeloid leukemia have been reported to be secondary to treatment with Methotrexate, but are very uncommon. We report here the first Moroccan case of RA patient on low dose MTX, who developed AML. We also reviewed all similar cases.
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Clinical and experimental rheumatology
دوره 22 5 Suppl 35 شماره
صفحات -
تاریخ انتشار 2004